News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Elisa Agostinetto: Blinded independent central review (BICR) in clinical trials is it really needed
Photo taken from Elisa Agostinetto/X
Dec 20, 2023, 12:00

Elisa Agostinetto: Blinded independent central review (BICR) in clinical trials is it really needed

Elisa Agostinetto, Medical Research Fellow at Jules Bordet Institute in Brussels, recently posted X/Twitter:

”Blinded independent central review (BICR) in clinical trials: is it really needed. In this meta-analysis out in EJC we found no difference in PFS by BICR vs. by local assessment. BICR costs and complexity in clinical trials free link here.”

Elisa Agostinetto: Blinded independent central review (BICR) in clinical trials is it really needed

Source: Elisa Agostinetto/X

Blinded independent central review cancer clinical trials Elisa Agostinetto meta-analysis OncoDaily Oncology
Special Coverage
Blog
Jan 15, 2025, 13:07
Yan Leyfman: Using routine blood tests to predict immunotherapy response across multiple cancers
Blog
Jan 15, 2025, 13:05
Douglas Flora: Association of Cancer Care Centers just pledged to match $10,000 in donations to Firefighter Cancer Support Network
Blog
Jan 15, 2025, 13:03
Ellen Sigal: Ready to get back to work and continue fighting to ensure every patient has access to the most innovative medicines
Blog
Jan 15, 2025, 13:00
Ray Bai: Methods and Applications for Bayesian Semiparametric Survival Analysis
Blog
Jan 15, 2025, 11:08
Why Dana-Farber Direct Connect? - Dana-Farber Cancer Institute
Blog
Jan 15, 2025, 10:56
Sachin H. Jain: The path forward for the US Health Insurance Industry begins with saying “We Are Sorry”
Blog
Jan 15, 2025, 08:23
Pashtoon Kasi: Different kind of liquid biopsies in guiding care of patients with cancer
Blog
Jan 15, 2025, 08:14
Chokri Ben Lamine: Immune Targets in Hematologic Malignancies
Blog
Jan 15, 2025, 08:06
Shushan Hovsepyan: 20 million participants at the first-ever 2025 CACA-OncoDaily-SPCC Cancer Summit
Opinion
Jan 15, 2025, 07:58
The Power of Equity: Funding Research to Close Gaps in Colorectal Cancer Outcomes
Blog
Jan 15, 2025, 07:53
Moses Echodu: Recounting 2024 and Looking at 2025 - Growth and Acceleration
Blog
Jan 15, 2025, 07:49
Breaking Ground in Genomics: India Launches "Genome India" Database - Canary Oncoceutics